Ticker: MGTX

Quick take - MeiraGTx Holdings plc (NASDAQ: MGTX) What's happening inside: management is pivoting toward partnership-led funding and commercial manufacturing while continuing heavy clinical investment. The company closed a strategic collaboration with Hologen (large upfront and follow‑on funding ...

MeiraGTx Holdings plc (NASDAQ: MGTX) is a clinical-stage gene therapy company facing continued financial challenges as indicated in its recent quarterly report for Q1 2025. Key Points from the Q1 2025 Income Statement: Service revenue increased to $1.926 million from $0.697 million in Q1 2024, r...